scholarly article | Q13442814 |
P2093 | author name string | C Caux | |
S Lebecque | |||
A Vicari | |||
A Zlotnik | |||
F Brière | |||
J M Bridon | |||
B Vanbervliet | |||
E Oldham | |||
M C Dieu | |||
S Aït-Yahia | |||
P2860 | cites work | A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells | Q24311809 |
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors | Q24314660 | ||
STRL22 is a receptor for the CC chemokine MIP-3alpha | Q24317562 | ||
Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2 | Q24321318 | ||
Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells | Q24321607 | ||
Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7 | Q24322056 | ||
Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells | Q24652902 | ||
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells | Q24652932 | ||
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
A new generation of Ca2+ indicators with greatly improved fluorescence properties | Q27860793 | ||
Cloning and characterization of exodus, a novel beta-chemokine | Q28118401 | ||
Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC | Q28239561 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells | Q28264381 | ||
Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro | Q28291482 | ||
Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta | Q28302521 | ||
Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2 | Q28307054 | ||
Chemokines | Q29616435 | ||
The dendritic cell system and its role in immunogenicity | Q29619870 | ||
Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes | Q34274604 | ||
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. | Q34418838 | ||
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines | Q34662656 | ||
IL-2 mRNA expression in Tac-positive malignant lymphomas | Q35811193 | ||
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells | Q59067424 | ||
Dendritic cells capable of stimulating T cells in germinal centres | Q60085015 | ||
Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture | Q68927623 | ||
Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells | Q71017514 | ||
Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines | Q71746654 | ||
Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence | Q72412476 | ||
Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization | Q72630496 | ||
Overview of chemokines | Q72759203 | ||
The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation | Q74195817 | ||
Mature dendritic cells respond to SDF-1, but not to several beta-chemokines | Q74484195 | ||
Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function | Q93522010 | ||
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes | Q36028490 | ||
Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo | Q36230770 | ||
Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing | Q36231441 | ||
Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations | Q36231905 | ||
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro | Q36349915 | ||
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ | Q36352646 | ||
Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain | Q36353782 | ||
Migration and maturation of Langerhans cells in skin transplants and explants | Q36353813 | ||
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells | Q36354420 | ||
Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues | Q36354492 | ||
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells | Q36356239 | ||
Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium | Q36362334 | ||
Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces | Q36363011 | ||
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro | Q36363984 | ||
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells | Q36364036 | ||
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 | Q36364968 | ||
Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. | Q36367109 | ||
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q36367113 | ||
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. | Q36367475 | ||
Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes | Q36376839 | ||
B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement | Q36400397 | ||
Induction of G protein-coupled peptide receptor EBI 1 by human herpesvirus 6 and 7 infection in CD4+ T cells | Q36626183 | ||
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies | Q38518849 | ||
Fas ligation induces apoptosis of CD40-activated human B lymphocytes | Q39018355 | ||
Chemokines, leukocyte trafficking, and inflammation | Q40502969 | ||
The molecular biology of leukocyte chemoattractant receptors | Q40661169 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Chemokine receptors: gateways to inflammation and infection | Q41193992 | ||
Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization | Q41206634 | ||
Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes | Q41819359 | ||
Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo | Q41872431 | ||
Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid | Q42848458 | ||
Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone | Q42939048 | ||
Ceramide inhibits antigen uptake and presentation by dendritic cells | Q42948037 | ||
Lymph-borne dendritic leucocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells | Q44111468 | ||
Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration | Q44988525 | ||
Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells | Q44990569 | ||
Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines | Q48045988 | ||
Chemokines and the arrest of lymphocytes rolling under flow conditions. | Q52040689 | ||
In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. | Q52112187 | ||
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis | Q57275941 | ||
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells | Q57275942 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 373-386 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites | |
P478 | volume | 188 |
Q45885513 | 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity |
Q93133060 | A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials |
Q24291798 | A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells |
Q92412632 | A Novel Gastric Spheroid Co-culture Model Reveals Chemokine-Dependent Recruitment of Human Dendritic Cells to the Gastric Epithelium |
Q92644008 | A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia |
Q40464167 | A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. |
Q54238056 | A guide to chemokines and their receptors. |
Q73166178 | A migratory population of skin-derived dendritic cells expresses CXCR5, responds to B lymphocyte chemoattractant in vitro, and co-localizes to B cell zones in lymph nodes in vivo |
Q37215891 | A new mechanism for inhalational priming: IL-4 bypasses innate immune signals |
Q36983731 | A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration |
Q46613321 | A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes. |
Q34465399 | A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection |
Q33981265 | A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection |
Q52630379 | A synthetic peptide derived from the parasite Toxoplasma gondii triggers human dendritic cells' migration. |
Q42944753 | Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. |
Q36376581 | Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin |
Q33269201 | Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques |
Q34584253 | Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens |
Q40554106 | Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response |
Q40633211 | Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protei |
Q50088601 | Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells |
Q62658261 | Actualités physiologiques et physiopathologiques des cellules dendritiques |
Q38119559 | Adoptive transfusion of tolerance dendritic cells prolongs the survival of skin allografts in mice: a systematic review |
Q36905986 | Advances in the immunopathophysiology of the idiopathic inflammatory myopathies: not as simple as suspected |
Q33754959 | Aged Lymphatic Vessels and Mast Cells in Perilymphatic Tissues. |
Q47896454 | Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter |
Q38425485 | Airway epithelium interactions with aeroallergens: role of secreted cytokines and chemokines in innate immunity |
Q40280731 | An age-structured model of dendritic cell trafficking in the lung. |
Q36228128 | An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium |
Q40198172 | An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses |
Q35366220 | An overview of lymphatic vessels and their emerging role in cardiovascular disease |
Q39752844 | Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium |
Q35553632 | Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses |
Q81468340 | Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells |
Q39007282 | Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer. |
Q52012326 | Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. |
Q47288431 | Applications of chemokines as adjuvants for vaccine immunotherapy |
Q99711514 | Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression |
Q35768336 | Assignment of CCR7 gene to chicken chromosome 27 by radiation hybrid panel mapping |
Q34663921 | Association between regulated upon activation, normal T cells expressed and secreted (RANTES) -28C/G polymorphism and susceptibility to HIV-1 infection: a meta-analysis |
Q42665157 | Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions |
Q37721153 | Atopic dermatitis: the role of Langerhans cells in disease pathogenesis |
Q34296482 | Attractions and migrations of lymphoid cells in the organization of humoral immune responses |
Q33897693 | Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance |
Q33776141 | B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions |
Q22010648 | Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 |
Q33754936 | Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. |
Q44491491 | Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis |
Q37516516 | Blood dendritic cells: "canary in the coal mine" to predict chronic inflammatory disease? |
Q57808232 | C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release |
Q41911701 | CCL19 reduces tumour burden in a model of advanced lung cancer |
Q51673501 | CCL20 is an inducible product of human airway epithelia with innate immune properties. |
Q39968006 | CCL20 production is induced in human dental pulp upon stimulation by Streptococcus mutans and proinflammatory cytokines |
Q33878671 | CCL20/CCR6 expression profile in pancreatic cancer |
Q34206158 | CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells |
Q33940793 | CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells |
Q36675842 | CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. |
Q36488901 | CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors |
Q37849901 | CCR6 as a mediator of immunity in the lung and gut. |
Q36980670 | CCR6 as a possible therapeutic target in psoriasis |
Q44600233 | CCR6 has a non‐redundant role in the development of inflammatory bowel disease |
Q33697355 | CCR6 ligands inhibit HIV by inducing APOBEC3G. |
Q37599020 | CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype |
Q33904793 | CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. |
Q36163017 | CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses |
Q35553563 | CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues |
Q24316090 | CCR7 and its ligands: balancing immunity and tolerance |
Q28594485 | CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs |
Q40283805 | CCR7 deficiency modulates T cell response and increases susceptibility to Yersinia pseudotuberculosis infection. |
Q28592208 | CCR7 ligand-enhanced phagocytosis of various antigens in mature dendritic cells-time course and antigen distribution different from phagocytosis in immature dendritic cells |
Q54510584 | CCR7 ligands up-regulate IL-23 through PI3-kinase and NF-κ B pathway in dendritic cells. |
Q28507848 | CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells |
Q33980867 | CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease |
Q37647096 | CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters. |
Q48268022 | CD40 Mediates Maturation of Thymic Dendritic Cells Driven by Self-Reactive CD4+ Thymocytes and Supports Development of Natural Regulatory T Cells |
Q42742311 | CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants |
Q37073770 | CD83+CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease. |
Q36732325 | CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition |
Q42518050 | CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells |
Q24295909 | Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells |
Q40469665 | Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response. |
Q38352871 | Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. |
Q40797136 | Cell culture conditions affect LPS inducibility of the inflammatory mediators in J774A.1 murine macrophages |
Q28263920 | Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo |
Q42222800 | Chemerin suppresses murine allergic asthma by inhibiting CCL2 production and subsequent airway recruitment of inflammatory dendritic cells |
Q73219365 | Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor |
Q39619150 | Chemokine Receptor CCR3 Expression in Malignant Cutaneous Tumors |
Q34117128 | Chemokine and chemokine receptor dynamics during genital chlamydial infection |
Q30874259 | Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells |
Q52347151 | Chemokine and chemotactic signals in dendritic cell migration. |
Q39218317 | Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation |
Q45106160 | Chemokine receptor CCR6 transduces signals that activate p130Cas and alter cAMP-stimulated ion transport in human intestinal epithelial cells |
Q28268587 | Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics |
Q35849720 | Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses |
Q33683322 | Chemokine receptor trafficking and viral replication |
Q81214042 | Chemokine receptor-mediated delivery of mycobacterial MPT51 protein efficiently induces antigen-specific T-cell responses |
Q74481121 | Chemokine receptors |
Q33919892 | Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines |
Q56943251 | Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines |
Q37773282 | Chemokine-chemokine receptors in cancer immunotherapy |
Q37332946 | Chemokine-directed strategies to attenuate allograft rejection |
Q33726199 | Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma |
Q26774619 | Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview |
Q77723690 | Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses |
Q36521144 | Chemokines and chemokine receptors in scleroderma |
Q34002668 | Chemokines and dendritic cell traffic. |
Q81618796 | Chemokines and inflammatory skin diseases |
Q33887484 | Chemokines and myeloid cell recruitment |
Q34756572 | Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs |
Q93001507 | Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers |
Q37256207 | Chemokines and transplant vasculopathy |
Q33792344 | Chemokines as Cancer Vaccine Adjuvants. |
Q47719808 | Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. |
Q34119204 | Chemokines in cancer |
Q34296506 | Chemokines in immunity |
Q35216944 | Chemokines in the systemic organization of immunity |
Q34547756 | Chemokines, innate and adaptive immunity, and respiratory disease |
Q29615663 | Chemokines: a new classification system and their role in immunity |
Q34139595 | Chemokines: immunology's high impact factors |
Q82616885 | Chemokines: more than just road signs |
Q43192962 | Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E(2) and nitric oxide. |
Q47164996 | Circulating CCL20 as a New Biomarker of Abdominal Aortic Aneurysm. |
Q36488894 | Clinical utilization of chemokines to combat cancer: the double-edged sword |
Q34555051 | Co-delivery of ccl19 gene enhances anti-caries DNA vaccine pCIA-P immunogenicity in mice by increasing dendritic cell migration to secondary lymphoid tissues |
Q35595246 | Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease |
Q34582640 | Combinations of immunotherapy and radiation in cancer therapy. |
Q79248342 | Comparative evaluation of CC chemokine-induced migration of murine CD8α+ and CD8α− dendritic cells and their in vivo trafficking |
Q61698866 | Comparison of α-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients |
Q36756615 | Complement component 3C3 and C3a receptor are required in chitin-dependent allergic sensitization to Aspergillus fumigatus but dispensable in chitin-induced innate allergic inflammation |
Q34632575 | Construction and in vitro evaluation of a recombinant live attenuated PRRSV expressing GM-CSF |
Q99709099 | Contributions of Major Cell Populations to Sjögren's Syndrome |
Q50096567 | Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3alpha/CCL20. |
Q38097034 | Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells |
Q28590726 | Cutting Edge: NLRP12 Controls Dendritic and Myeloid Cell Migration To Affect Contact Hypersensitivity |
Q44592649 | Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression |
Q33874509 | Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization |
Q35237489 | DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling |
Q34090282 | DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells |
Q37628687 | DNA microarrays provide new options for allergen testing |
Q38883160 | Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis |
Q37598660 | Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions |
Q55322533 | Dendritic Cell Migration Toward CCL21 Gradient Requires Functional Cx43. |
Q38740877 | Dendritic Cell Trafficking and Function in Rare Lung Diseases |
Q48293590 | Dendritic Cell-Based Cancer Vaccines |
Q28067403 | Dendritic Cell-T-Cell Circuitry in Health and Changes in Inflammatory Bowel Disease and Its Treatment |
Q38786002 | Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools |
Q48738306 | Dendritic cell adhesion to cerebral endothelium: role of endothelial cell adhesion molecules and their ligands |
Q34129744 | Dendritic cell biology and regulation of dendritic cell trafficking by chemokines |
Q33889300 | Dendritic cell dynamics in the liver and hepatic lymph |
Q36229426 | Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo |
Q34023428 | Dendritic cell regulation of TH1-TH2 development |
Q21284774 | Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation |
Q47880928 | Dendritic cell-derived tumor necrosis factor α modifies airway epithelial cell responses. |
Q37038464 | Dendritic cells and contact dermatitis |
Q35178634 | Dendritic cells and host resistance to infection. |
Q34216506 | Dendritic cells and immunotherapy for malignant disease |
Q35584599 | Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? |
Q36425922 | Dendritic cells as promoters of transplant tolerance |
Q43475387 | Dendritic cells from human mesenteric lymph nodes in inflammatory and non-inflammatory bowel diseases: subsets and function of plasmacytoid dendritic cells |
Q36933225 | Dendritic cells in allergic airway inflammation |
Q34430740 | Dendritic cells in cancer vaccines |
Q80897522 | Dendritic cells in colonic patches and iliac lymph nodes are essential in mucosal IgA induction following intrarectal administration via CCR7 interaction |
Q37591719 | Dendritic cells in intestinal homeostasis and disease. |
Q39294119 | Dendritic cells in the host response to implanted materials |
Q36375059 | Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte respons |
Q38113759 | Dendritic cells of the oral mucosa |
Q33931602 | Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs. |
Q34842438 | Dendritic cells, chemokine receptors and autoimmune inflammatory diseases |
Q33653670 | Dendritic cells. |
Q51949586 | Dendritic cells: a family portrait at mid-gestation. |
Q33541967 | Dendritic cells: a link between innate and adaptive immunity |
Q35620073 | Dendritic cells: emerging pharmacological targets of immunosuppressive drugs |
Q33762520 | Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis? |
Q34386066 | Dendritic cells: their significance in health and disease |
Q33989067 | Dendritic-cell trafficking to lymph nodes through lymphatic vessels |
Q38469509 | Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner |
Q36368436 | Developmental switches in chemokine response profiles during B cell differentiation and maturation |
Q38373693 | Different Expression of Interferon-Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells Based on Their Maturation State |
Q35024786 | Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. |
Q46889551 | Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs |
Q28214991 | Differentiated keratinocytes are responsible for TNF-alpha regulated production of macrophage inflammatory protein 3alpha/CCL20, a potent chemokine for Langerhans cells |
Q38317327 | Differentiation and activation of equine monocyte-derived dendritic cells are not correlated with CD206 or CD83 expression. |
Q35848403 | Discovery of novel immunostimulants by dendritic-cell-based functional screening. |
Q34270621 | Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice |
Q48109150 | Distinct features of dendritic cell-based immunotherapy as cancer vaccines |
Q73170422 | Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity |
Q54093362 | Distinct patterns and kinetics of chemokine production regulate dendritic cell function. |
Q57041925 | Distribution, location, and transcriptional profile of Peyer’s patch conventional DC subsets at steady state and under TLR7 ligand stimulation |
Q34595212 | Downregulation of key early events in the mobilization of antigen-bearing dendritic cells by leukocyte immunoglobulin-like Receptor B4 in a mouse model of allergic pulmonary inflammation |
Q39808301 | Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation |
Q37324843 | Dynamic interactions between T cells and dendritic cells and their derived cytokines/chemokines in the rheumatoid synovium |
Q42527548 | ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3alpha gene expression in Caco-2 human colonic epithelial cells |
Q35102854 | Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis |
Q42149105 | Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma |
Q35041525 | Effect of chemokine receptors CCR7 on disseminated behavior of human T cell lymphoma: clinical and experimental study |
Q34447976 | Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. |
Q90533271 | Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles |
Q36627931 | Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines |
Q95781067 | Effects of MIP-1α, MIP-3α, and MIP-3β on the Induction of HIV Gag-specific Immune Response with DNA Vaccines |
Q24795082 | Effects of chemokines on proliferation and apoptosis of human mesangial cells |
Q52811140 | Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy. |
Q43690846 | Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells |
Q37770212 | Enemy at the gates: dendritic cells and immunity to mucosal pathogens |
Q81439332 | Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma |
Q38543768 | Engineering immunity in the mucosal niche against sexually transmitted infections. |
Q36113094 | Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis |
Q33939602 | Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes |
Q40434909 | Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors |
Q28612022 | Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway |
Q33705361 | Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma |
Q38159802 | Evolution of oncolytic viruses: novel strategies for cancer treatment |
Q35238598 | Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection. |
Q36504956 | Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma |
Q37460185 | Exposure to Cigarette Smoke Disrupts CCL20-Mediated Antimicrobial Activity in Respiratory Epithelial Cells. |
Q35023778 | Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses |
Q42445930 | Expression of CS-1 fibronectin precedes monocyte chemoattractant protein-1 production during elicitation of allergic contact dermatitis. |
Q49366827 | Expression of Membrane-Bound CC Chemokine Ligand 20 on Follicular T Helper Cells in T-B-Cell Conjugates |
Q40849688 | Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis |
Q48127836 | Expression of factors involved in dental pulp physiopathological processes by nemotic human pulpal fibroblasts |
Q34008399 | Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy |
Q73100417 | Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis |
Q39604025 | Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays |
Q28216686 | Expression of the C-C chemokine MIP-3 alpha/CCL20 in human epidermis with impaired permeability barrier function |
Q33802831 | Expression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma |
Q37013881 | Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease |
Q33232975 | Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus |
Q30574017 | Extracellular transport of cell-size particles and tumor cells by dendritic cells in culture |
Q73595188 | FLT3 ligand gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens |
Q75202388 | Fascin-positive dendritic cells and fibroblastic reticulum cells build a framework of T-cell areas in lymph nodes |
Q40274661 | Female genital tract immunization: evaluation of candidate immunoadjuvants on epithelial cell secretion of CCL20 and dendritic/Langerhans cell maturation |
Q34009066 | Filarial antigens impair the function of human dendritic cells during differentiation |
Q33949995 | Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. |
Q34681201 | Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium |
Q43855400 | Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging |
Q36108239 | From optical bench to cageside: intravital microscopy on the long road to rational vaccine design |
Q33840553 | From synapses to immunological memory: the role of sustained T cell stimulation |
Q39912198 | Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking |
Q53582682 | Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells. |
Q73047663 | Functional flexibility in T cells: independent regulation of CD4+ T cell proliferation and effector function in vivo |
Q27307097 | Functional identification of dendritic cells in the teleost model, rainbow trout (Oncorhynchus mykiss) |
Q54280525 | Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. |
Q33236495 | Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice |
Q37954393 | Gene expression profile of lymphatic endothelial cells |
Q45856772 | Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival |
Q44684461 | Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2). |
Q44606718 | Genetic co-transfer of CCR7 ligands enhances immunity and prolongs survival against virulent challenge of pseudorabies virus. |
Q40568230 | Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis |
Q35040829 | Genetically modified dendritic cells--a new, promising cancer treatment strategy? |
Q35649464 | German cockroach proteases and protease-activated receptor-2 regulate chemokine production and dendritic cell recruitment |
Q41951345 | Gliadin fragments promote migration of dendritic cells |
Q36952955 | Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth |
Q35988809 | HIV-1 and the hijacking of dendritic cells: a tug of war. |
Q33597237 | HIV: The deadly passenger in dendritic cells |
Q34672927 | Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells |
Q35038298 | Hepatic T cells and liver tolerance |
Q35963122 | High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. |
Q34712641 | How dendritic cells and microbes interact to elicit or subvert protective immune responses |
Q40372115 | Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions. |
Q57295207 | Human Dendritic Cells: Ontogeny and Their Subsets in Health and Disease |
Q52920401 | Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity. |
Q42095200 | Human Lymph Node-Derived Fibroblastic and Double-Negative Reticular Cells Alter Their Chemokines and Cytokines Expression Profile Following Inflammatory Stimuli |
Q27649353 | Human Macrophage Inflammatory Protein 3 : Protein and Peptide Nuclear Magnetic Resonance Solution Structures, Dimerization, Dynamics, and Anti-Infective Properties |
Q38722955 | Human Three-Dimensional Endometrial Epithelial Cell Model To Study Host Interactions with Vaginal Bacteria and Neisseria gonorrhoeae. |
Q44792124 | Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils |
Q36684512 | Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality |
Q36354718 | Human dendritic cell subsets for vaccination |
Q40762192 | Human macrophage inflammatory protein-3alpha/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-alpha via a non-standard NF-kappaB site |
Q73734449 | Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells |
Q36017166 | Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells |
Q39111149 | Hypoxia preconditioning of mesenchymal stromal cells enhances PC3 cell lymphatic metastasis accompanied by VEGFR-3/CCR7 activation |
Q40781908 | IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. |
Q34243633 | III. Chemokines and other mediators, 8. Chemokines and their receptors in cell-mediated immune responses in the lung |
Q36731156 | IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells |
Q90110064 | IL-17 regulates DC migration to the peribronchial LNs and allergen presentation in experimental allergic asthma |
Q33723794 | IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. |
Q48025696 | IL4 and IFNalpha generation of dendritic cells reveals great migratory potential and NFkB and cJun expression in IL4DCs |
Q34585798 | IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells |
Q56943183 | Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma |
Q36456716 | Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice |
Q28142802 | Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning |
Q37262498 | Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cells |
Q45711436 | Identification of functional type 1 ryanodine receptors in mouse dendritic cells |
Q107377157 | Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients |
Q36059926 | Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies. |
Q38434343 | Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis |
Q39147683 | Immune modulation by dendritic-cell-based cancer vaccines |
Q36124506 | Immunologic roles of hyaluronan |
Q38179489 | Immunological milieu in mycosis fungoides and Sézary syndrome |
Q34609440 | Immunological principles of T-cell-mediated adverse drug reactions in skin |
Q45735802 | Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands |
Q36206601 | Immunotherapy in multiple myeloma--possibility or probability? |
Q33898020 | Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation |
Q35080114 | Impaired lung dendritic cell activation in CCR2 knockout mice |
Q40624760 | Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells |
Q36375533 | In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. |
Q54342274 | In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma. |
Q80398184 | In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response |
Q39885761 | In situ regulation of DC subsets and T cells mediates tumor regression in mice |
Q73023994 | In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sen |
Q43974400 | In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity |
Q33942185 | In vivo maturation and migration of dendritic cells |
Q34890142 | In vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model |
Q34376166 | In vivo requirement for Atg5 in antigen presentation by dendritic cells |
Q54477202 | Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. |
Q39357136 | Increased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration |
Q24673314 | Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors |
Q48008663 | Increased expression of CCL20 in human inflammatory bowel disease |
Q33212277 | Increased lymphocyte trafficking to colonic microvessels is dependent on MAdCAM-1 and C-C chemokine mLARC/CCL20 in DSS-induced mice colitis |
Q28141189 | Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis |
Q36441408 | Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. |
Q43830776 | Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine |
Q39896570 | Infection-mimicking materials to program dendritic cells in situ |
Q37670964 | Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ. |
Q52006445 | Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. |
Q35751000 | Influence of ERK activation on decreased chemotaxis of mature human cord blood monocyte-derived dendritic cells to CCL19 and CXCL12 |
Q42972688 | Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. |
Q35053924 | Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. |
Q38816202 | Innate immunity in HIV-1 infection: epithelial and non-specific host factors of mucosal immunity- a workshop report. |
Q33425860 | Interaction between CXCR4 and CCL20 pathways regulates tumor growth |
Q41988896 | Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression. |
Q34007420 | Interaction of dendritic cells with mycobacteria: where the action starts |
Q36367773 | Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance |
Q33502716 | Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells |
Q43835536 | Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation |
Q28083455 | Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis |
Q84529622 | Interleukin-4 enhances trafficking and functional activities of GM-CSF-stimulated mouse myeloid-derived dendritic cells at late differentiation stage |
Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
Q37700153 | Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathology |
Q35829642 | Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis |
Q35988030 | Intratumoral immunotherapy: using the tumour against itself |
Q35946403 | Involvement of dendritic cells in autoimmune diseases in children |
Q36108089 | Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? |
Q48912189 | Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). |
Q43079558 | Kaposi's sarcoma-associated herpesvirus kaposin B induces unique monophosphorylation of STAT3 at serine 727 and MK2-mediated inactivation of the STAT3 transcriptional repressor TRIM28. |
Q34652126 | Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation. |
Q45002113 | Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis |
Q36692263 | Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses |
Q37331247 | Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one? |
Q45021061 | Leptin expression in healthy and inflamed human dental pulp. |
Q46422409 | Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections |
Q36368440 | Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine |
Q36366975 | Location, movement and survival: the role of chemokines in haematopoiesis and malignancy. |
Q38883153 | Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. |
Q33951970 | Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus |
Q34216061 | Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction. |
Q28388881 | Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat |
Q34139610 | Lymphocyte traffic control by chemokines |
Q34488105 | Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen |
Q54515978 | MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood. |
Q39404775 | MIP-3α expression in macrophages is NOD dependent |
Q40590387 | MMP-9/TIMP-1 imbalance induced in human dendritic cells by Porphyromonas gingivalis |
Q37241383 | Macrophage Inflammatory Protein-3 Alpha (MIP-3α)/CCL20 in HIV-1-Infected Individuals |
Q36368813 | Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. |
Q24671761 | Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells |
Q35159565 | Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth |
Q24681359 | Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue |
Q52007110 | Macrophage inflammatory protein-3alpha and beta-defensin-2 stimulate dentin sialophosphoprotein gene expression in human pulp cells. |
Q42048427 | Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue |
Q37045841 | Managing Crohn disease in children and adolescents : focus on tumor necrosis factor antagonists |
Q34772018 | Mast cell activators: a new class of highly effective vaccine adjuvants |
Q37538259 | Mast cells and histamine are triggering the NF-κB-mediated reactions of adult and aged perilymphatic mesenteric tissues to acute inflammation |
Q61053890 | Maturation of DC is associated with changes in motile characteristics and adherence |
Q36275693 | Maturation of function in dendritic cells for tolerance and immunity. |
Q46816706 | Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs |
Q37497528 | Mature dendritic cell derived from cryopreserved immature dendritic cell shows impaired homing ability and reduced anti-viral therapeutic effects |
Q82305772 | Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration |
Q61448759 | Maturing Human CD127+ CCR7+ PDL1+ Dendritic Cells Express AIRE in the Absence of Tissue Restricted Antigens |
Q58619973 | Maximizing dendritic cell migration in cancer immunotherapy |
Q50907039 | Mechanically Enhanced Hierarchically Porous Scaffold Composed of Mesoporous Silica for Host Immune Cell Recruitment. |
Q37272221 | Mechanisms and consequences of dendritic cell migration |
Q35748581 | Mechanisms of dendritic cell trafficking across the blood-brain barrier |
Q35787649 | Mechanisms of infliximab: the reverse side of a drug effect |
Q34236194 | Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis |
Q64099517 | Meta-analysis of the prognostic value of C-C chemokine receptor type 7 in patients with solid tumors |
Q42064511 | Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization |
Q36369047 | Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses |
Q34250645 | Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. |
Q86857534 | Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses |
Q42576422 | Mobilizing dendritic cells for tolerance, priming, and chronic inflammation |
Q37256953 | Modeling the immune rheostat of macrophages in the lung in response to infection |
Q36421498 | Modulation of pulmonary dendritic cell function during mycobacterial infection. |
Q29622852 | Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 |
Q44366911 | Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen |
Q28586719 | NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells |
Q37921195 | Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals |
Q33530090 | Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice |
Q37589059 | New insights into the molecular pathogenesis of langerhans cell histiocytosis |
Q37361936 | New insights into the roles of dendritic cells in intestinal immunity and tolerance |
Q34529798 | New twists to an old story: novel concepts in the pathogenesis of allergic eye disease |
Q39587450 | Non-proteolytic house dust mite allergen, Der p 2, upregulated expression of tight junction molecule claudin-2 associated with Akt/GSK-3β/β-catenin signaling pathway. |
Q37022848 | Noncanonical dendritic cell differentiation and survival driven by a bacteremic pathogen. |
Q36504368 | Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis |
Q38057797 | Novel pharmacological approaches for treatment of obstructive sleep apnea in children |
Q38544776 | Ocular Surface as Barrier of Innate Immunity |
Q36726165 | Ocular surface expression and in vitro activity of antimicrobial peptides |
Q42039828 | Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. |
Q35848756 | Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells |
Q36938511 | Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists |
Q47907252 | Outer membrane protein A (OmpA) activates human epidermal Langerhans cells |
Q34124931 | PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells |
Q36384618 | PGE2-induced metalloproteinase-9 is essential for dendritic cell migration |
Q35809825 | Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells |
Q24643034 | Pathogen recognition and inflammatory signaling in innate immune defenses |
Q36388701 | Pathogenic T-cell recruitment into the airway in human disease. |
Q38450454 | Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. |
Q73955068 | Phenotype and function of human dendritic cells derived from M-DC8(+) monocytes |
Q74734253 | Phenotype, antigen-presenting capacity, and migration of antigen-presenting cells in young and old age |
Q45245826 | Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination |
Q34167920 | Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection |
Q57275922 | Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon |
Q42112622 | Pollen allergens do not come alone: pollen associated lipid mediators (PALMS) shift the human immune systems towards a T(H)2-dominated response |
Q40427880 | Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials |
Q40646496 | Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes |
Q37352177 | Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. |
Q33677473 | Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes |
Q38076137 | Prion disease and the innate immune system |
Q39707819 | Production of macrophage inflammatory protein 3alpha (MIP-3alpha) (CCL20) and MIP-3beta (CCL19) by human peripheral blood neutrophils in response to microbial pathogens |
Q33929076 | Progress in cancer vaccines by enhanced self-presentation |
Q40777523 | Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB [correction of NK-kappaB]. |
Q37859271 | Prostaglandin E2 modulates dendritic cell function during chlamydial genital infection |
Q28473223 | Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells |
Q74329922 | Psoriasis scales contain C5a as the predominant chemotaxin for monocyte-derived dendritic cells |
Q34316777 | Quality assessment of cellular therapies: the emerging role of molecular assays |
Q42496158 | Quantitative morphological analysis of Langerhans cells in healthy and diseased human gingiva |
Q34529895 | Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination |
Q28251005 | Recent advances in the understanding of Langerhans cell histiocytosis |
Q38073096 | Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers |
Q62065031 | Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections |
Q46130061 | Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity |
Q27023950 | Regulation of atherogenesis by chemokine receptor CCR6 |
Q35615906 | Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function |
Q36371607 | Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming |
Q39345479 | Regulation of the exopolysaccharide from an anamorph of Cordyceps sinensis on dendritic cell sarcoma (DCS) cell line |
Q28237665 | Regulation of the immune response by the interaction of chemokines and proteases |
Q41963849 | Relationship of vaccine efficacy to the kinetics of DC and T-cell responses induced by PLG-based cancer vaccines |
Q42132231 | Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells |
Q36369526 | Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation |
Q47741693 | Respiratory sensitization: toxicological point of view on the available assays |
Q28538588 | Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation |
Q42208901 | Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C. |
Q90216632 | Role of CCR7 on dendritic cell‑mediated immune tolerance in the airways of allergy‑induced asthmatic rats |
Q26849785 | Role of G protein-coupled receptors in control of dendritic cell migration |
Q47973596 | Role of Macrophage Inflammatory Protein-3α and Its Ligand CCR6 in Rheumatoid Arthritis |
Q98292008 | Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies |
Q37754929 | Role of dendritic cells in the lung: in vitro models, animal models and human studies |
Q45387326 | Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells |
Q89783319 | Role of microRNAs in the Regulation of Dendritic Cell Generation and Function |
Q40355478 | Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skin dendritic cell line. |
Q39681071 | Roxithromycin downregulates production of CTACK/CCL27 and MIP-3α/CCL20 from epidermal keratinocytes. |
Q55342016 | SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. |
Q35917624 | Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease |
Q78952383 | Secondary lymphoid organ chemokines are elevated in the cerebrospinal fluid during central nervous system inflammation |
Q37548085 | Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen |
Q33820420 | Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. |
Q35978569 | Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection |
Q39707033 | Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa |
Q28138084 | Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans |
Q52018468 | Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. |
Q36165903 | Selective suppression of leukocyte recruitment in allergic inflammation |
Q40306042 | Seminal plasma promotes the attraction of Langerhans cells via the secretion of CCL20 by vaginal epithelial cells: involvement in the sexual transmission of HIV. |
Q26752817 | Sensitivity of Dendritic Cells to Microenvironment Signals |
Q37028329 | Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells |
Q40485606 | Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response |
Q33943427 | Shaping and tuning of the chemokine system by regulation of receptor expression and signaling: dendritic cells as a paradigm. |
Q41945985 | Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties |
Q31830489 | Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages. |
Q37177696 | Simian immunodeficiency virus interactions with macaque dendritic cells |
Q46648209 | Solar-simulated ultraviolet radiation induces abnormal maturation and defective chemotaxis of dendritic cells |
Q40149278 | Soluble mediators produced by the crosstalk between microvascular endothelial cells and dengue-infected primary dermal fibroblasts inhibit dengue virus replication and increase leukocyte transmigration |
Q53623000 | Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. |
Q38510124 | Spiral ligament fibrocytes release chemokines in response to otitis media pathogens |
Q57198394 | Strategies to Stimulate Innate Immunity for Designing Effective Vaccine Adjuvants |
Q34103579 | Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells |
Q44294573 | Superoxide anions induce the maturation of human dendritic cells |
Q39506242 | Suppression of metastatic murine ovarian cancer cells by transduced embryonic progenitor cells |
Q40181085 | Suppression of the bacterial antigen-specific T cell response and the dendritic cell migration to the lymph nodes by osteopontin |
Q73371191 | T-cell immune responses in the brain and their relevance for cerebral malignancies |
Q34272048 | Targeted therapy for malignant melanoma |
Q34588561 | Targeting vaccines to dendritic cells |
Q38668284 | Technical Advance: New in vitro method for assaying the migration of primary B cells using an endothelial monolayer as substrate |
Q54958028 | Tetraspanins as Organizers of Antigen-Presenting Cell Function. |
Q37298535 | Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. |
Q50131761 | The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis |
Q30333360 | The CC chemokine CCL20 and its receptor CCR6. |
Q36369301 | The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment |
Q24298508 | The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed |
Q35145988 | The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation |
Q37159454 | The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. |
Q33650445 | The chemokine system: redundancy for robust outputs |
Q24675048 | The class 6 semaphorin SEMA6A is induced by interferon-gamma and defines an activation status of langerhans cells observed in pathological situations |
Q33840529 | The control of T cell responses by dendritic cell subsets |
Q34184752 | The dendritic cell in allergic airway diseases: a new player to the game |
Q94511936 | The differential role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in the adherence, migration and podosome formation of human macrophages and dendritic cells under inflammatory conditions |
Q38956221 | The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma |
Q42016734 | The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. |
Q36368355 | The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli |
Q35210456 | The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors |
Q24672653 | The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12 |
Q24671078 | The induction of tolerance by dendritic cells that have captured apoptotic cells |
Q34282306 | The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics |
Q51816597 | The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function. |
Q41467713 | The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans |
Q73467410 | The novel mechanism of peripheral tolerance |
Q34493082 | The role of chemokines in linking innate and adaptive immunity |
Q36817201 | The role of complement and Toll-like receptors in organ transplantation |
Q34712656 | The role of dendritic cells during Salmonella infection |
Q33887435 | The role of dendritic cells in the innate immune system. |
Q35219319 | The role of dendritic cells in the pathogenesis of HIV-1 infection |
Q55270960 | The role of nanoliposome bilayer composition containing soluble leishmania antigen on maturation and activation of dendritic cells. |
Q53114768 | The several elements of intestinal innate immune system at the beginning of the life of broiler chicks. |
Q37997315 | The specialized roles of immature and mature dendritic cells in antigen cross-presentation |
Q46741854 | The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo |
Q37044769 | The spleen's role in transplantation immunology |
Q37415953 | The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules |
Q36371677 | The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. |
Q43470518 | The synthetic peptides bovine enteric β-defensin (EBD), bovine neutrophil β-defensin (BNBD) 9 and BNBD 3 are chemotactic for immature bovine dendritic cells |
Q44220341 | The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway |
Q35947673 | Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32. |
Q73927474 | Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma |
Q49242675 | Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity. |
Q50863800 | Toll-Like Receptor 9 Agonists for Cancer Therapy. |
Q29547305 | Toll-like receptor control of the adaptive immune responses |
Q37340298 | Toll-like receptors and cancer |
Q36483050 | Toll-like receptors and corneal innate immunity |
Q35774952 | Toll-like receptors and immune response in allergic disease |
Q28209227 | Toll-like receptors as adjuvant receptors |
Q36819003 | Transcription factors in the control of dendritic cell life cycle |
Q96767810 | Transcriptomic profiling of bovine blood dendritic cells and monocytes following toll-like receptor stimulation |
Q34842268 | Travellers in many guises: the origins and destinations of dendritic cells |
Q35039049 | Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking |
Q56966063 | Tumor Necrosis Factor-α- and IL-4-Independent Development of Langerhans Cell-Like Dendritic Cells from M-CSF-Conditioned Precursors |
Q39958799 | Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice |
Q52720866 | Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma. |
Q36627887 | Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity |
Q38086506 | Tumour necrosis factor in infectious disease. |
Q58862665 | Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha |
Q36577550 | Tumour-induced immune modulation of sentinel lymph nodes |
Q33515288 | Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes. |
Q83831241 | Ultraviolet B radiation suppresses Langerhans cell migration in the dermis by down-regulation of alpha4 integrin |
Q59713916 | Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys |
Q35947218 | Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis |
Q49334976 | Use of antigen-primed dendritic cells for inducing antitumor immune responses in vitro in patients with non-small cell lung cancer |
Q62083293 | VLA-5 and transendothelial migration |
Q34610624 | Vaccination strategies to promote mucosal antibody responses. |
Q36375683 | Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma |
Q45406264 | Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells |
Q34306330 | Variation in innate immunity genes and risk of multiple myeloma |
Q52552996 | Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. |
Q74309792 | [Dendritic cells and the control of the immune response] |